Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Active, not recruiting Not applicable

Community-Empowerment and Environmental Enrichment-based Co-management (CEEEC) Model and Mechanisms for Improving Health of Older Stroke Patients With Multimorbidity

NCT06975501 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2025-06-20
Last updated
2026-10-29

Condition(s) studied

HypertensionType 2 Diabetes Mellitus (T2DM)MultimorbidityStroke

Investigational drug(s) / intervention(s)

Exercise InterventionCognitive Intervention

Exercise Intervention: Participants will receive twice-weekly aerobic and balance training sessions, with medication compliance education.

Cognitive Intervention: Participants will participate in twice-weekly structured cognitive training sessions, with medication compliance education.

Study summary

This study is a cluster randomized controlled trial with a 2×2 factorial design conducted in community health centers in Kunshan, Wuhan and Shanghai, China. It aims to evaluate the independent and combined effects of exercise and cognitive interventions on intrinsic capacity and related health outcomes among stroke survivors aged 60 years and older with hypertension or type 2 diabetes mellitus. Participants will receive either exercise training, cognitive training, combined training, or usual care over 20 week, followed by a 12\~24 month follow-up. Findings will inform integrated health management strategies for older adults with multimorbidity.

Eligibility

Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged ≥60 years * The doctor diagnosed it as a stroke and it is in a stable stage (the diagnosis time is not limited) * Patients with concurrent hypertension and/or diabetes may also have other diseases at the same time * Be able to participate in a community intervention lasting for six months * Be informed and agree to participate in the research Exclusion Criteria: * With the aid of a walking aid (not a wheelchair), it is also impossible to walk independently to the community service center. * Lack basic communication skills and do not recognize Arabic numerals * Suffering from life-threatening diseases, with a survival expectation of less than 6 months, etc.

Primary outcome measure(s)

  • Intrinsic Capacity (World Health Organization Integrated Care for Older People) — 20 weeks
    Assessment of intrinsic capacity using the World Health Organization Integrated Care for Older People (WHO ICOPE) framework.

Trial sites (1)

FacilityCityRegionStatus
Duke Kunshan University Suzhou Jiangsu
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06975501 on ClinicalTrials.gov ↗ ← All trials in China